Work

Molecular Mechanisms Mediating Relapse Following Ivosidenib Monotherapy in Patients with IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-122671

Authors: Sung Choe, Hongfang Wang, Courtney D. DiNardo, Eytan M. Stein, Stephane De Botton, Amir T. Fathi, Martin S. Tallman, Hagop M. Kantarjian, Richard M. Stone, Lynn Quek, Zenon Konteatis, Lenny Dang, Vickie Zhang, Hua Liu, Eyal C. Attar, Bin Wu

Institutions: Agios Pharmaceuticals (United States), The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Institut Gustave Roussy, Massachusetts General Hospital, Dana-Farber Cancer Institute, University of Oxford

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2990363589

Cites:

Cited by: 6

Related to: 10